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of WNK1, a Kinase that Causes
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genesis analysis revealed that a different lysine residue
in strand 2 (subdomain I) was necessary for kinase
activity (Xu et al., 2000). The kinase domains of the WNK
kinases possess no more than 29% (to Ste20) sequence
identity with other protein kinases. They are found only
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Medical Center at Dallas in multicellular organisms (Verissimo and Jordan, 2001;
Xu et al., 2000); there are four homologs in human, at5323 Harry Hines Boulevard
Dallas, Texas 75390 least two in rat and mouse, one in C. elegans, and Dro-
sophila, and nine in Arabidopsis thaliana.
The physiological roles of WNK kinases were com-
pletely unknown until the recent findings that pseudohy-Summary
poaldosteronism type II (PHAII), an autosomal dominant
disorder featuring hypertension, was shown to beWNK kinases comprise a small group of unique serine/
caused by mutations in two of the four human WNKthreonine protein kinases that have been genetically
kinases, WNK1 and WNK4 (Wilson et al., 2001). Givenlinked to pseudohypoaldosteronism type II, an autoso-
the sensitivity of PHAII patients to thiazide diuretics, anmal dominant form of hypertension. Here we present
antagonist of the Na-Cl cotransporter (NCCT), it wasthe structure of the kinase domain of WNK1 at 1.8 A˚
postulated that upregulation of the NCCT could be theresolution, solved in a low activity conformation. A
cause (Wilson et al., 2003; Yang et al., 2003). In studieslysine residue (Lys-233) is found in the active site ema-
directed toward understanding the roles of WNK1 andnating from strand 2 rather than strand 3 as in other
WNK4 in pseudohypoaldosteronism II, it was found thatprotein kinases. The activation loop adopts a unique
wild-type WNK4 reduced the levels of the Na-Cl cotrans-well-folded inactive conformation. The conformations
porter, when coexpressed in Xenopus ooccytes. Theof the P1 specificity pocket, the placement of the
reduction in NCCT levels occurred only when using wild-conserved active site threonine (Thr-386), and the ex-
type WNK4, but not with kinase-dead WNK4 or oneterior placement of helix C, contribute to the low activ-
of the disease-causing mutants (Q565E) (Wilson et al.,ity state. By homology modeling, we identified two
2003; Yang et al., 2003). The disease-causing mutationshydrophobic residues in the substrate-binding groove
in WNK1 are large intronic deletions that increase itsthat contribute to substrate specificity. The structure
expression in kidney. When coexpressed with WNK4,of the WNK1 catalytic domain, with its unique active
WNK1 abolishes the inhibitory effect of WNK4 on NCCT,site, may help in the design of therapeutic reagents
having no affect on the NCCT activity on its own (Yangfor the treatment of hypertension.
et al., 2003). Thus, it appears that WNK1 and WNK4
have distinct and opposite roles in the regulation of ion
Introduction homeostasis. WNK4 is highly expressed in kidney, and
WNK1 is expressed ubiquitously. Using a yeast two-
Protein kinases are central signal transducers involved hybrid screen, Lee et al. showed that WNK1 binds to
in control of all facets of cell function, including changes synaptotagmin 2, and in vitro assays showed that WNK1
in the cellular program as well as cellular homeostasis. phosphorylates synaptotagmin 2 (B.H.L. et al., submit-
Recently, the human protein kinase superfamily was ted). Synaptotagmins are involved in membrane traffick-
estimated to possess just over 500 members (Kostich ing, and this activity could conceivably be involved in the
et al., 2002; Manning et al., 2002), which were classified mechanism by which WNK1 affects NCCT membrane
into seven major groups. In addition, a few less popu- expression levels. Xu et al. examined the ability of WNK1
lated groups have been identified. WNK kinases (with to activate MAP kinases, and found that overexpressed
no lysine [K]) (Xu et al., 2000, 2002) comprise a very small WNK1, when cotransfected with ERK5, activates this
group which have gained attention recently because two MAP kinase, suggestive of roles for WNK1 other than
of its members have been shown to be mutated in a in ion homeostasis (Xu et al., 2003).
form of Mendelian hypertension (Wilson et al., 2001). The kinase domains of the four human homologs
WNK kinases are unique among protein kinases in share approximately 80% sequence identity or better
lacking a conserved lysine residue (Lys-72 in cAMP- (Xu et al., 2000). Of the 2126 amino acids present in the
dependent protein kinase [PKA]) (Knighton et al., 1991) originally cloned splice form of rat WNK1, the serine/
from strand 3 (subdomain II, nomenclature defined in threonine protein kinase domain is near the N terminus
Hanks and Hunter [1998]), the residue most often mu- (amino acids 218–483). The sequence reveals relatively
tated to generate inactive protein kinases (Robinson et little secondary structure outside the kinase domain ex-
al., 1996). In WNK kinases, this lysine is replaced by a cept two coiled-coil domains (amino acids 563–597 and
cysteine. Nevertheless, at least two of the known WNK 1814–1841) in the C-terminal extension. However, se-
kinases have been shown to possess protein serine/ quence conservation across species in the C-terminal
threonine kinase activity, and model-building and muta- extensions suggests biological functions for these seg-
ments. Deletion analysis revealed an autoinhibitory seg-
ment between residue 490 and 550 (Xu et al., 2002). This*Correspondence: betsy@chop.swmed.edu
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segment is predicted to have an -helical secondary kinase groups. The overall fold resembles other protein
kinases with the typical dual domain architecturestructure using Jpred (Cuff et al., 1998), but it lacks
sequence identity to known domains. Mutagenesis anal- (Knighton et al., 1991) (Figure 1C). However, the N-ter-
minal domain is unique in having a six-stranded  sheetysis revealed that two phenylanaline residues (Phe-524
and Phe-526) within the autoinhibitory domain were es- that is rolled up to form a nearly complete  barrel. This
contrasts with the five-stranded  sheet found normally.pecially important to the autoinhibition. An autophos-
phorylation site (Ser-382) was identified in the activation The additional strand (labeled 0) (Figure 1B and 1C)
makes antiparallel  sheet hydrogen bonding interac-loop of the kinase domain, and this autophosphorylation
is required for the kinase activity (Xu et al., 2002). tions with 1 and part of the activation loop from the
second molecule in the asymmetric unit (between resi-To further understand the mechanism of specificity,
regulation, and catalysis of WNK protein kinases, we dues 380 and 383). Three of the canonical strands, 1,
4, and 5, are longer than normal, promoting the near have determined the structure of the kinase domain of
WNK1. We succeeded in crystallizing the low activity barrel. The phosphate anchor ribbon, strands 1 and 2,
adopt fairly normal positions, however. The C-terminalconformation in which the activation loop phosphoryla-
tion site serine was mutated to alanine (WNK1 194-483 has a standard architecture, and in the construct we
crystallized, there is no extension from the kinase core.S382A). The structure revealed the novel location of the
catalytic lysine in 2 (subdomain I). This unusual active
site may be advantageous in the development of specific
The Active Siteinhibitors targeted to WNK protein kinases. The low ac-
The WNK1 S382A mutant crystallized is inactive; auto-tivity structure is maintained by WNK-specific interac-
phosphorylation and activation is prevented by mutationtions of the activation loop. The structure, together with
of S382A. That the conformation is not active is mostpositions of amino acid replacements between WNK1
apparent because a highly conserved residue, Thr-386,and WNK4 which are known to have different substrates,
corresponding to Thr-201 in PKA, is not in the activesuggested possible site of substrate interactions. Muta-
site. The position of Thr-386 is influenced by the confor-tion of Val-318 and Ala-448 of WNK1 in the substrate
mation of the activation loop to which it is connected,binding groove predicted from PKA to those found in
and will be discussed below. Otherwise, much of theWNK4, abrogated binding to substrate synaptotagmin
active site appears normal. Conserved catalytic resi-2. The structure of WNK1 is also unique in that the
dues in the catalytic loop (Asp-349, Lys-351, and Asn-N-terminal domain  sheet is formed into a near  barrel,
354) (corresponding to Asp-166, Lys-168, and Asn-171through the addition of a  strand N-terminal to the
in PKA) adopt standard positions and peptide conforma-canonical kinase core, and lengthening of three of the
tions. However, each of these residues adopts different strands.
side chain conformations such that the hydrogen bond-
ing interactions expected on the basis of other kinase
Results and Discussion structures are not formed (Figure 2A).
The defining feature of the WNK kinase group is that
Full-length rat WNK1 expresses poorly both in bacteria they lack a catalytic lysine residue (Lys-72 in PKA) in
and in insect cells. A series of constructs that included strand 3 (subdomain II). This lysine residue normally
the wild-type kinase domain or the mutant S382A that forms an ion pair with a glutamic acid in helix C (Glu-
eliminated the phosphorylation site and flanking se- 91 of PKA) in active protein kinases (Bossemeyer et al.,
quences of varying length were tested for expression 1993; Knighton et al., 1991). The lysine residue also
in E. coli and crystallization. One construct, containing contacts the - and -phosphates of ATP, suggesting
residue 194–483 with the mutation S382A, was crystal- that the lysine-glutamate pair may be involved in proton-
lized (Figure 1A). The crystal belongs to space group ating product ADP, or performing some other acid base
P1 and there are two molecules in the asymmetric unit. function. In WNK1, a cysteine residue (Cys-250) occu-
Selenomethionine protein crystals diffract to a higher pies this position in strand 3 (subdomain II). However,
resolution than the native crystals. The structure was the side chain of the cysteine residue is far from the
solved by the single-wavelength anomalous dispersion active site, not likely a candidate for catalysis. A lysine
(SAD) method using a complete data set collected on residue (Lys-233) in strand 2 (subdomain I) reaches
a single selenomethionine crystal. The final structure into the active site. Previously, we showed by mutagene-
was refined in REFMAC5 (Murshudov et al., 1997) to sis that mutation of Lys-233 abolished kinase activity
an R factor of 18.9% (Rfree  22.7%) with reasonable (Xu et al., 2000). The structure confirms that the catalytic
stereochemistry (Table 1). The model contains 542 lysine in WNK1 is located in strand 2, not in 3 as in
amino acids from two WNK1 molecules and 351 water other protein kinases (Figure 2).
molecules. In one molecule, the first 17 residues at the Interestingly, WNK1 does possess the glutamate resi-
N terminus and three residues at the C terminus are due in helix C (Glu-268) that usually forms an ion pair
disordered. In the other molecule, the first 16 and last with the catalytic lysine, but here it does not form ion
2 residues are disordered. The average B factor of the pair with Lys-233. Instead it is 13 A˚ away, and forms a
model is 24 A˚2. different ion pair with Arg-348 of the catalytic loop, and
a hydrogen bond with Thr-373 in the activation loop
helix 310-L12 (Figure 3). The normal lysine-glutamate pairTopology of WNK1
The kinase domain of WNK1 shares 29% sequence iden- is also not present in low activity CDK2 (De Bondt et
al., 1993). To assess the function of this conserved gluta-tity with Ste20, and close to 25% identity with other
Crystal Structure of the Kinase Domain of WNK1
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Figure 1. General Topology of WNK1 Kinase Domain
(A) Schematic diagram of the WNK1 domain organization and the construct used in the crystallization. S/TPK, serine/threonine protein kinase
domain; CC, coiled-coil domain; Inh, autoinhibitory domain.
(B) Multiple sequence alignment of WNK1, WNK4, and cAMP-dependent protein kinase (PKA). Secondary structures are shown at the top of
the alignment. The nomenclature for the secondary structure elements follows that for PKA structure. The helix A and B, strand 6 and 9 are
not present. The sequences of the activation loop and catalytic loop are shown in red and yellow, respectively. The catalytic lysine Lys-233
and the typical lysine position residue Cys-250 in WNK1 are highlighted in red and marked with asterisks. Val-318 and Ala-448 are colored
blue.
(C) Ribbon representation of WNK1. The five conserved  strands are blue and  helices are magenta. The extra N-terminal  strand is shown
in gold. The activation loop is shown in red and the catalytic loop in yellow. Lys-233, Cys-250, Asp-368, and Thr-386 are shown in ball-and-
stick representation. The green balls represent two substrate-specificity determinant residue Val-318 and Ala-418. The figure is prepared
using Molscript (Kraulis, 1991) and GL-Render (L. Esser, personal communication). The multiple sequence alignment is prepared using T-Coffee
(Notredame et al., 2000).
mate, we mutated Glu-268 to glutamine. The mutant bone of the crossover connection, which in other kinases
binds the adenine ring of ATP, looks similar to PKA.could not be expressed, suggestive of an important role
for this residue in stabilizing the structure. However, the
results leave open the question of whether Glu-268 has Conformation of the Activation Loop
The unphosphorylated activation loop in the S382A mu-a catalytic function.
The unique catalytic residue, Lys-233, contributes to tant of WNK1 crystallized is well ordered throughout
and maintains a low activity conformation through inter-the different shape of the ATP binding site. A large cavity
is present in the back of the active site and near Cys- actions at both ends of the loop. First, at the N terminus
of the activation loop a two-turn 310-helix is formed (310-250. Further in the ATP binding site a glutamate residue
(Glu-127 of PKA), which binds to ATP in many protein L12) (Figure 3). This 310-helix is wedged between Phe-
232 at the tip of the phosphate anchor ribbon and helixkinases, is replaced by a threonine residue (Thr-308) in
WNK1, suggesting that ATP must be bound somewhat C, displacing helix C and Glu-268, from the catalytic
cleft. The contact between the helix 310- L12 and helix Cdifferently in WNK kinases. On the other hand, the back-
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Wild-type WNK1 kinase domain becomes autophos-Table 1. Details of Data Collection and Structure Determination
for the Selenomethionine WNK1 phorylated when expressed in both E. coli and insect
cells. From structural studies on other protein kinasesSpace group P1
determined in active conformation, it is known that theUnit cell a  38.30 A˚, b  57.77 A˚,
phosphorylated residue bound in a positively chargedc  65.66 A˚,   91.3,
  89.99,   90.89 pocket that forms in the subunit interface, for example
Resolution (A˚) 50–1.8 (1.86–1.8)a His-87, Arg-165, and Lys-189 in PKA, stabilizes the
Observed reflections 217,158 (21,551) phosphorylated residue Thr-197 (Bossemeyer et al.,
Unique reflections 50,614 (5,012)
1993; Knighton et al., 1991) (Figure 4B). These residuesRedundancy 4.3 (4.3)
are conserved in WNK kinases, suggestive that WNKCompleteness 97.6% (96.9%)
kinases are activated by a similar mechanism. In the lowRmergeb 0.077 (0.144)
I/I 27.9 (10.7) activity structure determined here, none of the putative
Rcrystc 0.189 phosphate ligands is formed into a pocket: Lys-375 (cor-
Rfreed 0.228 responding to Lys-189 in PKA) interacts with catalytic
Number of groups
aspartic acid Asp-348. Arg-264 (corresponding to His-Protein atoms 4,706
87) is solvent exposed. Arg348 (corresponding to Arg-Water 345
165) interacts with conserved glutamate Glu-268 inRmsd in bond lengths (A˚) 0.010
Rmsd in bond angles (o) 1.18 helix C.
Average B factor (A˚2) 24.02 The activation loop of WNK1 forms extensive interac-
Ramachandran statistics (%) tions with the N-terminal domain of the neighboring mol-
Most favored regions 90.7
ecule in the crystal (discussed below). This affects theAdditional allowed regions 8.0
position of four residues (Ala-380 to Val-383). However,Generously allowed regions 0.6
the configuration of most part of the activation loop isDisallowed regionse 0.6
not directly affected by this intermolecular interaction.a Values between parentheses are for the highest resolution shell.
Also, the intramolecular interactions at both ends of theb Rmerge  |(Ihkl) 	 
I|/(Ihkl), where Ihkl is the integrated intensity of
activation loop are extensive, apparently having domi-a given reflection.
c Rcryst||Fobs|	 k|Fcalc||/|Fobs|, where Fobs and Fcalc are the observed nating roles in stabilizing the conformation, suggesting
and calculated structure factors, respectively. that they are not artifacts of the crystallization.
d Rfree is calculated as Rcryst using 5% of the reflection data chosen
randomly and omitted from the refinement calculations.
e Supported by excellent electron density. An Extensive Lattice Contact
Two molecules of WNK1 in the unit cell form an unusual
crystal contact: the activation loop of a neighboring mol-is primarily hydrophobic and involves Phe-265 and Leu-
ecule is inserted between 4 and 0 in the N-terminal272 in helix C, and Leu-369 and Leu-374 in helix 310-L12.
domain to complete the  barrel noted above (FigureLeu-374 in helix 310-L12 also contacts Phe-232 in the
5). Four residues, Ala-380, Lys-381, Ala-382 (S382A,phosphate anchor ribbon. The observed conformation
mutated phosphorylation site), and Val-383 (prime re-is supported by interactions between Thr-373 of helix
fers to the residue in the neighboring molecule) from310-L12, Glu-268 in helix C, and Arg-348 in the catalytic
the activation loop of a neighboring molecule, form loop (RD motif) (as noted above). Arg-348, which in ac-
sheet hydrogen bonds with Val-212 and Met-214 in 0,tive protein kinases forms contacts with the activating
and Glu-288 and Thr-290 in 4. The sheet is not continu-phosphorylation site, adopts an unusual left-hand con-
ous, however; one end of the strand is interacting onlyformation (  82;   	17) in making the interaction.
with 0 and the other only with 4. The interaction sur-The structure of the N terminus of the activation loop
face also includes G, the loop connecting C and 4,has features in common with low activity CDK2 in which
which interacts with the 4/5 loop and 2/3 loop froma helix (L12) displaces helix C from the active site de-
the second molecule respectively.stroying the catalytic lysine-glutamate ion pair (De
The two molecules in the asymmetric unit are similarBondt et al., 1993).
but not identical. Superposition of the N-terminal do-Second, the C terminus of the activation loop adopts
mains and C-terminal domains of the two moleculesa unique inactive conformation. The conserved residue
gives a root-mean-square deviation (rmsd) of 1.0 andThr-386 (corresponding to Thr-201 in PKA) is displaced
0.6 A˚ respectively, whereas the overall superposition isabout 10 A˚ from its expected position (Figure 4A). The
worse, 1.3 A˚, due to small differences in domain orienta-remodeling extends into the bottom of the P1 site
tion. The larger rmsd between N-terminal domains is(expected by homology to be formed by residues Val-
mainly due to differences in the lattice contacts.383 to Met-390). The last remodeled residue is Phe-389
The lattice contact interaction is present for each mol-in the sequence VIGTPEFMAPE, and Met-390 adopts a
ecule in the crystal lattice. The patterns of interactionsnormal position. Remodeling of the P1 pocket occurs
are also similar for each molecule in the lattice. Suchin the low activity forms of p38 (Wang et al., 1997) and
interactions apparently do not occur in solution sincePAK1 (Lei et al., 2000); the remodeling here is unique
WNK1 kinase domain is soluble and monomeric as as-however. The activation loop makes extensive van der
sessed by gel filtration. The lattice provides a glimpseWaals contacts with the linker (L14) between helices F
of how the activation loop of kinases becomes extendedand G and the beginning of helix G involving the Val-
to bind in the active site of another kinase to become383 and Pro-387 in the loop. This represents an outward
phosphorylated and is reminiscent of the CDK2-KAPdisplacement of the activation loop that creates another
large unique cavity adjacent to the active site. complex (Song et al., 2001) (Figure 5). Considering the
Crystal Structure of the Kinase Domain of WNK1
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Figure 2. Comparison of the Active Site of WNK1 and PKA
(A) Stereo diagram of the active site of WNK1. Seven catalytic residues are shown in ball-and-stick representation.
(B) 2Fo 	 Fc electron density map of the phosphate anchor ribbon contoured at 1 level.
(C) The active site of PKA. Residues corresponding to WNK1 are shown in ball-and-stick representation. The ion pair interactions between
Lys-72 and Glu-91 and the hydrogen bonds between Thr-201 and Lys-168 and Asp-166 in PKA are displayed in green dotted lines. These
interactions are not present in WNK1.
lattice contact from the point of view of the N-terminal a homology-based structural model of WNK4 using the
domain  sheet, it is not known whether the contact is WNK1 coordinates based on the multiple sequence
a mimic for substrate or autoinhibitory interactions. alignment (Figure 1B), and found two residues in the
substrate binding groove that might be involved in sub-
strate recognition. The two residues, Val-318 (in the loopSubstrate Binding Site and Specificity
between helices D and E) and Ala-448 (in the loop be-In a yeast two-hybrid study directed toward identifying
tween helix H and Helix I), are replaced by glutamatepossible physiological substrates of WNK1, Lee et al.
and lysine respectively in WNK4 (Figure 1B). The WNK1showed that synaptotagmin 2, a calcium sensor protein
mutant (V318E/A448K) did not bind to synaptotagmin 2involved in membrane trafficking, binds to WNK1 (B.H.L.
C2A or C2B domains as assessed by direct yeast two-et al., submitted). Using different fragments of synapto-
hybrid experiment, but retained binding to another pro-tagmin 2, it was shown that WNK1 interacts with the C2
tein found in the dual hybrid screen (B.H.L. et al., submit-domain of synaptotagmin 2. This interaction is specific
ted). This suggests that the two residues play majorfor WNK1; the closely related WNK4 (83% identity in the
roles mediating the stable binding between WNK1 andkinase domain) does not bind synaptotagmin 2 in a two-
synaptotagmin 2.hybrid test (B.H.L. et al., in submitted). We examined
We next examined the effect of these mutations on thethe kinase activity of WNK1 and WNK4 on substrate
phosphorylation reactions. The mutant WNK1 showedsynaptotagmin 2. WNK4 phosphorylates synaptotagmin
slightly higher autophosphorylation than wild-type (data2 only poorly (Figure 6A). To gain insight into the basis
for this difference in substrate specificity, we generated not shown), suggesting that the mutant retained cata-
Structure
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WNK1 probably has a hydrophobic binding pocket for
the P1 residue. From mass spectrometry, two phos-
phorylation sites in synaptotagmin 2 have been identi-
fied; one is followed by a leucine residue and another
by a glutamate residue (B.H.L., submitted). Apparently,
the P1 residue is not a strong specificity determinant
for WNK1.
Conclusions
As anticipated from the sequences of WNK kinases and
biochemical studies, WNK1 indeed does not have the
catalytic lysine in 3 (subdomain II) common to all of
the major groups of protein kinases, but instead pos-
sesses a catalytic lysine in 2 (subdomain I, Lys-233).
The functional significance of the catalytic lysine place-
ment in WNK1 is unknown. It is interesting that WNK1
kinase phosphorylates synaptotagmin 2 C2 domains.
This well-folded substrate is different from many protein
kinase substrates in which the sites of phosphorylation
are in extended polypeptides or in very long loops that
can be remodeled to bind in the active site of the protein
kinase. The placement of the catalytic lysine may be
necessary for alignment of its well-folded substrate intoFigure 3. Extensive Interactions between the N-Terminal Helix of
the kinase active site. Coincidently, a very distant homo-the Activation Loop with Helix C
log of protein kinases, aminoglycoside kinase APH(3)-Helices and strands are colored as in Figure 1.
IIIa, has lysine residues in both 2 and 3 position (Hon
et al., 1997). The position of catalytic lysine in 2 in
WNK kinases may be related to some yet to identifiedlytic activity. The double mutation V318E/A448K in
WNK1 decreased its activity toward specific substrate regulatory mechanism. In any case, the different active
site of WNK1 should be helpful in development of WNK1-synaptotagmin 2 (40%–50%), although the activity is not
as low as that of WNK4 (Figure 6B). Combining the stable specific inhibitors.
The extent of remodeling of the activation loop ofbinding assay and phosphorylation data, it is suggested
that the two residues are important substrate specificity WNK1 is also interesting. The low activity forms of most
protein kinases are remodeled at either one end of thedeterminants that mediates the specific interactions be-
tween WNK1 and synaptotagmin 2. loop or the other. For example, low activity CDK2 has
conformational changes in the N terminus of the loop,The structure of WNK1 solved is in low activity confor-
mation, and the P1 specificity pocket is not formed affecting helix C (De Bondt et al., 1993; Jeffrey et al.,
1995), and MAP kinases have changes at the C terminus(Figure 4). Sequence similarity with PKA suggests that
Figure 4. Conformation of the C Terminus of the Activation Loop
The P1 site residues and positive charge residues that bind phosphate group of WNK1 (A) are compared with PKA (B).
Crystal Structure of the Kinase Domain of WNK1
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Figure 5. The Lattice Contact Interactions in WNK1
(A) One of the WNK1 lattice contact interactions. One molecule is colored as in Figure 1. The second molecule is displayed with green 
strands and gold  helices. The interface consists of the activation loop of the first monomer and the N-terminal domain of the second.
(B) Structural superposition of WNK1 with CDK2 in complex with specific phosphatase KAP. WNK1 is shown in magenta. The activation loop
and catalytic loop of WNK1 are highlighted in red and yellow respectively. CDK2 is colored in gray. The structure of KAP is removed for better
view of the activation loop of CDK2.
(Canagarajah et al., 1997; Zhang et al., 1994), affecting a kinase activation loop can fit into the active site of
another enzyme for phosphorylation or dephosphoryla-the conserved threonine and the P1 specificity pocket.
Low activity WNK1 has both of these changes. In this tion. The large cavity created in this conformation may
offer further opportunities for drug development.respect, WNK1 resembles PAK1 which is also remod-
eled throughout the activation loop (Lei et al., 2000). WNK kinases are regulated by autoinhibition from se-
quences outside the kinase domain. Also, WNK1 mayThe exterior position of the activation loop, apparently
promoted by a lattice contact, offers a glimpse of how be present in a large protein complex in the cell (our
Figure 6. Substrate Specificity Determinant in WNK1
(A) Top panel, WNK1 (194-483) and WNK4 (141-436) were used in kinase assays with GST-syt2 (141-422) as substrate. The phosphorylation
of GST-syt2 (141-422) and autophosphorylation of WNK1 and WNK4 are shown. Bottom panel, SDS-PAGE of the kinase assay.
(B) Top panel, wild-type WNK1 (194-483) and mutant WNK1 (194-483 V318E/A448K) were used in kinase assay with GST-syt2 (141-422) and
His-syt2 (81-422) as substrates. The phosphorylations of both synaptotagmins are shown and the fold changes of the phosphorylation reactions
are labeled below the autoradiogram. Bottom panel, SDS-PAGE of the kinase assay.
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formed in 30 l of kinase buffer (20 mM HEPES, pH 7.6, 10 M ATP,unpublished data). Thus, further studies are required to
10 M 10 mM MgCl2, 10 mM -glycerophosphate, 1 mM dithiothrei-understand how this unusual serine/threonine protein
tol, and 1 mM benzamidine) containing 10Ci of [-32P] ATP. Recom-kinase is regulated. Perhaps these other interactions
binant WNK1 and synaptotagmin 2 were added at final concentra-
will offer further clues concerning the function of the tions of 1 and 0.7M, respectively. Kinase reactions were terminated
lysine in  strand 2. with 5l SDS sample buffer followed by boiling 2 min.
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